ASX:PYCBiotechs
What PYC Therapeutics (ASX:PYC)'s CFO Appointment of Biotech Finance Veteran Means For Shareholders
PYC Therapeutics Limited recently appointed Thomas Ulmer as Chief Financial Officer, bringing 20 years of international leadership experience across biotechnology, pharmaceuticals and healthcare, including senior roles at Cell Therapies, PKG Health, Immatics N.V., Allergopharma and Merck Group.
Ulmer’s prior involvement in leading Immatics N.V. through a NASDAQ listing adds capital markets and listing experience that could be important for PYC Therapeutics’ future corporate and financing...